WHO-GMP Certified Facility

Mirabegron API Manufacturer in India: Direct Factory Sourcing

CPPL / Blog / Mirabegron API Manufacturer in India: Direct Factory Sourcing
Mirabegron API manufacturer in India

Mirabegron API Manufacturer in India: Direct Factory Sourcing

Mirabegron API Manufacturer in India – Direct Factory Sourcing

Mirabegron isn’t an easy API to make well. Unlike simpler small molecules, its synthesis involves multiple stages of amine intermediate chemistry, heterocyclic ring formation, and chiral resolution  meaning the manufacturer behind your supply matters more here than it does for many other APIs. If you’re searching for a Mirabegron API manufacturer in India, the difference between a company that actually runs this synthesis in-house and one reselling material sourced elsewhere shows up directly in your batch consistency and documentation depth.

This guide covers what to look for in a genuine Mirabegron API manufacturer, why India remains a strong sourcing base for this API, and what buying at factory pricing actually means for your formulation.

Why Mirabegron API Demand Is Growing

Mirabegron, a beta-3 adrenergic receptor agonist, has become a preferred treatment option for overactive bladder (OAB) largely because it avoids the cognitive and cardiovascular side effects associated with older antimuscarinic medications. It’s also indicated for neurogenic detrusor overactivity in pediatric patients three years of age and older weighing 35kg or more, giving it relevance across both adult and pediatric urology formulations. As global awareness of OAB treatment options grows alongside an aging population, demand for reliable, well-documented Mirabegron API supply has been climbing steadily.

Why Mirabegron’s Synthesis Complexity Matters for Sourcing

Mirabegron API production requires a multi-step synthesis route involving amine intermediate chemistry, heterocyclic ring construction, and chiral resolution to achieve the correct stereochemical purity. This complexity means:

  • Not every manufacturer can produce it consistently at scale — the process demands more process control and analytical capability than simpler APIs.
  • Chiral purity directly affects product quality, making impurity and stereochemical control a genuine differentiator between suppliers, not just a documentation formality.
  • Traders reselling Mirabegron API often can’t speak to the process behind it, since they aren’t the ones running the synthesis or controlling its chiral resolution step.

For a molecule this technically demanding to manufacture, buying from a company that actually understands and controls its own synthesis route is a meaningfully different proposition than buying from a reseller.

Why India Remains a Strong Source for Mirabegron API

India’s pharmaceutical manufacturing base combines deep synthetic chemistry expertise with WHO-GMP certified production infrastructure and decades of export experience — a combination well suited to a technically demanding API like Mirabegron. For global formulators, sourcing from an established Indian manufacturer offers both the process sophistication this molecule requires and pricing that remains competitive against other major manufacturing hubs.

What to Look for in a Mirabegron API Manufacturer in india

  1. In-house synthesis capability — confirm the company actually runs the full multi-step process, including chiral resolution, rather than outsourcing or reselling.
  2. WHO-GMP certification — verify the certificate names the specific facility producing your material.
  3. Chiral purity and impurity documentation — request analytical data specific to stereochemical purity, not just a general assay figure.
  4. Direct facility and technical access — a real manufacturer can answer specific process questions without relaying them to a third party.
  5. R&D capability — given the molecule’s synthesis complexity, a manufacturer with active process development capability is better positioned to maintain and improve quality over time.

Chemox Pharma: Mirabegron API Manufacturer, Dahej, Gujarat

Chemox Pharma manufactures Mirabegron API at our own WHO-GMP certified facility in Dahej, Gujarat — we are the factory running this synthesis, not a reseller. Our facility follows WHO-GMP, FDA, and DCGI-aligned regulatory standards, and our dedicated R&D centre supports the process development and quality optimization work that a technically complex API like Mirabegron demands.

Buying direct from Chemox Pharma means factory pricing with no middleman markup, consistent batch quality from a single controlled production source, and direct access to our team for documentation or technical questions specific to Mirabegron’s synthesis and chiral purity.

Questions to Ask Before You Order

  • Do you run the full synthesis in-house, including chiral resolution, or are you reselling material from elsewhere?
  • Can you provide chiral purity and impurity data specific to my batch?
  • Can I confirm your facility location and review your GMP certificate?
  • Can I speak directly with your production or QA team if a technical question comes up?

Request a Quote Direct From the Manufacturer

If you’re sourcing Mirabegron API and want factory pricing from a manufacturer that actually controls its own synthesis process, get in touch with Chemox Pharma for a quote and sample evaluation.

FAQs

Q: What is Mirabegron’s CAS number?

Mirabegron’s CAS number is 223673-61-8.

Q: Why is Mirabegron API harder to source reliably than other APIs?

Its synthesis requires multiple stages of amine intermediate chemistry, heterocyclic ring formation, and chiral resolution — a more technically demanding process than many simpler small-molecule APIs, making manufacturer capability a bigger differentiator.

Q: Is Chemox Pharma the actual manufacturer of Mirabegron API?

Yes. Chemox Pharma manufactures Mirabegron API at its own WHO-GMP certified facility in Dahej, Gujarat, running the full synthesis process in-house.

Q: What is Mirabegron API used for?

Mirabegron is used in formulations for overactive bladder in adults and neurogenic detrusor overactivity in pediatric patients three years of age and older weighing 35kg or more.

Leave a Reply

Your email address will not be published. Required fields are marked *